发明名称 ORGANIC COMPOUNDS
摘要 <p>A compound of formula (I), or tautomers, or stereoisomers, or solvates, or pharmaceutically acceptable salts thereof, wherein M&lt;SUB&gt;1&lt;/SUB&gt;, M&lt;SUB&gt;2&lt;/SUB&gt;, L&lt;SUB&gt;1&lt;/SUB&gt;, L&lt;SUB&gt;2&lt;/SUB&gt;, W&lt;SUB&gt;1&lt;/SUB&gt;, W&lt;SUB&gt;2&lt;/SUB&gt;, X&lt;SUB&gt;1&lt;/SUB&gt;, X&lt;SUB&gt;2&lt;/SUB&gt;, Y&lt;SUB&gt;1&lt;/SUB&gt;, Y&lt;SUB&gt;2&lt;/SUB&gt;, A, R&lt;SUP&gt;5&lt;/SUP&gt; and R&lt;SUP&gt;5a&lt;/SUP&gt; are as defined herein for the for treatment of conditions treatable by the blockade of an epithelial sodium channel, particularly conditions benefiting from mucosal hydration.</p>
申请公布号 WO2008135557(A1) 申请公布日期 2008.11.13
申请号 WO2008EP55497 申请日期 2008.05.05
申请人 NOVARTIS AG;FAIRHURST, ROBIN ALEC;BUTLER, REBECCA;OAKLEY, PAUL;COLLINGWOOD, STEPHEN PAUL;SMITH, NICHOLA;STANLEY, EMILY;RODRIGUEZ PEREZ, MARIA INES 发明人 FAIRHURST, ROBIN ALEC;BUTLER, REBECCA;OAKLEY, PAUL;COLLINGWOOD, STEPHEN PAUL;SMITH, NICHOLA;STANLEY, EMILY;RODRIGUEZ PEREZ, MARIA INES
分类号 C07D401/14;A61K31/497;A61P11/00;A61P29/00 主分类号 C07D401/14
代理机构 代理人
主权项
地址